Even though PPARγ’s primary function is in adipose tissue, where the highest expression levels are seen, patients with NAFLD have much higher hepatic expression levels of PPARγ, reflecting the fact that different tissues and cell types play different roles for PPARγ in different contexts. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.